Nebulized Ketamine to Nebulized Fentanyl for Treating Acute Painful Conditions in the ED

PHASE4RecruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Pain, Acute

Interventions

DRUG

Ketamine

Nebulized ketamine administered at 0.75 mg/kg via BAN

DRUG

Fentanyl

Nebulized fentanyl administered at 3 mcg/kg via BAN

Trial Locations (1)

RECRUITING

Maimonides Medical Center, Brooklyn

All Listed Sponsors

lead

Antonios Likourezos

OTHER